Safety and Efficacy of the DEVOIR Sirolimus-Coated Coronary Balloon in the Real-world Clinical Practice

Patient's inclusion and exclusion criteria are per device instructions for use's indications and contraindications. Inclusion criteria: 1. Patient is at least 18 years old 2. Lesion lengths ranging from 8 to 38 mm and diameters ranging from 1.50 mm to 4.00 mm. Exclusion criteria: 1. Patients with a hypersensitivity to Sirolimus drug or its structural activity related compounds. 2. Patients with a known hypersensitivity to excipients with phospholipid or related origins. 3. Patients whose diseased segment cannot be pre-dilated or prepared before drug coated balloon treatment. 4. Severely calcified lesions requiring treatment of other type for e.g. Rotational Atherectomy (Rotablator) 5. Patients judged to have lesion that prevents complete inflation of angioplasty balloon or proper placement of delivery catheter 6. Patients who cannot receive recommended antiplatelet or anticoagulation therapy.